These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 594841)

  • 1. [Serologic response to measles, rubella and parotitis vaccines].
    Ruíz-Gómez J; Alvarez y Muñoz MT; Jasso Gutiérrez L; Martínez Sánchez A
    Salud Publica Mex; 1977; 19(3):437-41. PubMed ID: 594841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications for possibilities of preventive vaccination against measles and rubella].
    Siegert R
    Internist (Berl); 1971 Aug; 12(8):309-12. PubMed ID: 4936452
    [No Abstract]   [Full Text] [Related]  

  • 5. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of mentally retarded subjects to measles, mumps and rubella vaccines.
    Sinha SK; Carlson SD
    Wis Med J; 1975 Jul; 74(7):75-7. PubMed ID: 1163054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with combined live measles and rubella vaccines.
    Ramos Alvarez M; Bessudo L
    Rev Invest Salud Publica; 1972; 32(2):110-5. PubMed ID: 4584450
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward prophylaxis of prenatal infection by viruses.
    Hilleman MR
    Obstet Gynecol; 1969 Apr; 33(4):461-9. PubMed ID: 4887325
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.
    Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH
    Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination against virus disease.
    Krugman S
    Maandschr Kindergeneeskd; 1968 Nov; 36(7):198-206. PubMed ID: 5715991
    [No Abstract]   [Full Text] [Related]  

  • 16. Mumps vaccination.
    Hilleman MR
    Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of a trivalent combined vaccine against measles, parotiditis and rubella].
    Randall AG; Leonard JM
    Salud Publica Mex; 1971; 13(3):313-7. PubMed ID: 5164661
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
    Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
    J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM; Arguedas JA; Buynak EB; Weibel RE; Stokes J; Hilleman MR
    J Pediatr; 1971 Oct; 79(4):599-604. PubMed ID: 5094254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.